Wells Fargo & Company Jasper Therapeutics, Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.42 - $0.93 $58 - $130	-140 Reduced 18.69%	609 $0
Q3 2023 Nov 13, 2023	SELL	$0.68 - $1.54 $32 - $73	-48 Reduced 6.02%	749 $0
Q2 2023 Aug 15, 2023	BUY	$1.19 - $1.79 $41 - $62	35 Added 4.59%	797 $1,000
Q1 2023 May 12, 2023	BUY	$1.48 - $2.74 $728 - $1,348	492 Added 182.22%	762 $1,000
Q4 2022 Feb 13, 2023	BUY	$0.46 - $8.9 $1 - $26	3 Added 1.12%	270 $0
Q3 2022 Nov 14, 2022	BUY	$0.08 - $22.6 $0 - $203	9 Added 3.49%	267 $0
Q2 2022 Aug 12, 2022	BUY	$1.73 - $3.86 $12 - $27	7 Added 2.79%	258 $0
Q4 2021 Feb 14, 2022	BUY	$7.21 - $16.42 $1,809 - $4,121	251 New	251 $2,000

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $843M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.